DeepMed Research

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Exploring a Potential Blood Test to Diagnose Major Depressive Disorder

Completed

Conditions: Major Depressive Disorder

First Posted Date: 2008-06-25

Last Posted Date: 2010-06-08

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 120

Registration Number: NCT00705185

Locations: 🇺🇸
University of Connecticut Health Center, Farmington, Connecticut, United States
🇺🇸
Psychiatric Medicine Associates, L.L.C., Chicago, Illinois, United States
🇺🇸
Cambridge Health Alliance, Cambridge, Massachusetts, United States

and more 2 locations

A Randomized Controlled Trial of Using Video Images in Dementia

Not Applicable

Completed

Conditions: Dementia

Interventions: Other: video

First Posted Date: 2008-06-25

Last Posted Date: 2009-06-23

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 200

Registration Number: NCT00704886

Locations: 🇺🇸
MGH, Boston, Massachusetts, United States

Dexmedetomidine Cardiovascular Safety in Pediatric Burn Patients

Phase 2

Completed

Conditions: Burns
Sedation

Interventions: Drug: Dexmedetomidine

First Posted Date: 2008-06-16

Last Posted Date: 2017-07-17

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 8

Registration Number: NCT00697788

Locations: 🇺🇸
Shriners Burn Hospital, Boston, Massachusetts, United States

Fetal Alcohol Damage Prevention Study

Not Applicable

Completed

Conditions: Fetal Alcohol Syndrome
Substance Abuse

Interventions: Behavioral: Brief motivational intervention

First Posted Date: 2008-06-12

Last Posted Date: 2008-06-12

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 612

Registration Number: NCT00696085

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Continuous Glucose Monitoring With a Subcutaneous Sensor During Critical Illness and Surgery

Not Applicable

Completed

Conditions: Critical Illness

Interventions: Device: Freestyle Navigator

First Posted Date: 2008-06-10

Last Posted Date: 2018-03-08

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 76

Registration Number: NCT00694473

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor

Phase 1

Completed

Conditions: Glioma

Interventions: Biological: GM-K562 Vaccination

First Posted Date: 2008-06-10

Last Posted Date: 2017-06-22

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 11

Registration Number: NCT00694330

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Partial Breast Irradiation (PBI) for Selected Patients With Early Invasive or Non-Invasive Breast Cancer

Not Applicable

Completed

Conditions: Ductal Breast Cancer

Interventions: Radiation: Partial Breast Irradiation using 32 Gy / 8 fractions
Radiation: Partial Breast Irradiation using 36 Gy / 9 fractions
Radiation: Partial Breast Irradiation using 40 Gy /10 fractions

First Posted Date: 2008-06-10

Last Posted Date: 2022-11-14

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 324

Registration Number: NCT00694577

Locations: 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

and more 1 locations

Comparison of Lantus and Neutral Protamine Hagedorn (NPH) Insulin in the Dawn Phenomenon

Phase 3

Completed

Conditions: Type 1 Diabetes
Dawn Phenomenon

Interventions: Drug: Lantus (glargine)

First Posted Date: 2008-06-10

Last Posted Date: 2014-10-21

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 27

Registration Number: NCT00694122

Locations: 🇺🇸
Massachusettes General Hospital/ Diabetes Research Center, Boston, Massachusetts, United States

Fentanyl Administered Intraorally for Rapid Treatment of Orthopedic Pain

Phase 1

Completed

Conditions: Pain, Fracture, Sprain

Interventions: Drug: Lansoprazole
Drug: Fentanyl
Drug: Oxycodone

First Posted Date: 2008-05-28

Last Posted Date: 2017-02-09

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 60

Registration Number: NCT00685295

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy

Phase 3

Completed

Conditions: Major Depressive Disorder

Interventions: Drug: Aripiprazole 5mg
Drug: Aripiprazole 2mg
Drug: Placebo

First Posted Date: 2008-05-26

Last Posted Date: 2017-07-19

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 225

Registration Number: NCT00683852

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy